欧盟EMA药品数据库(European Medicines Agency Authorisation of Medicines DataBase)
商品名称Ibaflin
适用类别Veterinary
治疗领域
通用名/非专利名称ibafloxacin
活性成分ibafloxacin
产品号EMEA/V/C/000052
患者安全信息No
许可状态Withdrawn
ATC编码QJ01MA96
是否额外监管No
是否仿制药或hybrid药物No
是否生物类似药No
是否附条件批准No
是否特殊情形No
是否加速审评No
是否罕用药No
上市许可日期2000/06/13
上市许可开发者/申请人/持有人Intervet International BV
人用药物治疗学分组
兽用药物治疗学分组Antibacterials for systemic use
欧盟委员会决定日期2010/05/26
修订号7
治疗适应症Dogs: Ibaflin is indicated for the treatment of the following conditions in dogs: dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible strains of Staphylococci, Escherichia coli and Proteus mirabilis; acute, uncomplicated urinary-tract infections, caused by susceptible strains of Staphylococci, Proteus species, Enterobacter spp., E. coli and Klebsiella spp.; respiratory-tract infections (upper tract) caused by susceptible strains of Staphylococci, E. coli, and Klebsiella spp. Ibaflin gel is indicated in dogs for the treatment of the following conditions: dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp., E. coli and P. mirabilis. Cats: Ibaflin gel is indicated in cats for treatment of the following conditions: dermal infections (soft-tissue infections - wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp., E. coli, Proteus spp. and Pasteurella spp.; upper respiratory-tract infections caused by susceptible pathogens such as Staphylococcus spp., E. coli, Klebsiella spp. and Pasteurella spp.
适用物种Dogs;Cats
兽用药物ATC编码QJ01MA96
首次发布日期2010/05/26
最后更新日期2013/07/10
产品说明书https://www.ema.europa.eu/en/documents/product-information/ibaflin-epar-product-information_en.pdf
公共评估报告https://www.ema.europa.eu/en/medicines/veterinary/EPAR/ibaflin
©2006-2025 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase